The COVID-19 pandemic has not impacted neuro-oncology patients’ satisfaction with outpatient visits, a survey suggests.
Patients reported similar satisfaction with telemedicine and in-person visits, and patient satisfaction scores were comparable before and during the pandemic.
These findings were presented in a poster at the Society for Neuro-Oncology (SNO) 2021 Annual Meeting.
Researchers evaluated satisfaction with in-person and telemedicine platforms among neuro-oncology patients treated at the Preston Robert Tisch Brain Tumor Center at Duke University in Durham, North Carolina.
Patients completed the Clinician & Group Consumer Assessment of Healthcare Providers and Systems survey, and the researchers compared pre-pandemic scores (April 2019 to March 2020) to scores from during the pandemic (April 2020 to March 2021).
There were 1448 survey results available. About half of them (48.6%) were from telemedicine visits during the pandemic.
Mean patient satisfaction scores before the pandemic were comparable to scores during the pandemic for all of the following measures:
- Overall provider rating (on a sale of 0 to 10) — 9.28 and 9.47, respectively
- Physician’s knowledge of the patient’s medical history — 96.9% and 95.4%, respectively
- Physician listens carefully to the patient — 96.6% and 96.9%, respectively
- Physician shows the patient respect — 97.2% and 98.1%, respectively
- Physician spends enough time with the patient — 93.2% and 95.5%, respectively.
The survey also revealed that, for all visits during the pandemic, mean patient satisfaction scores were similar for in-person visits and telemedicine visits:
- Overall provider rating — 9.29 and 9.48, respectively
- Physician’s knowledge of the patient’s medical history — 94.9% and 96.1%, respectively
- Physician listens carefully to the patient — 95.4% and 99%, respectively
- Physician shows the patient respect — 97.5% and 99%, respectively
- Physician spends enough time with the patient — 94.7% and 96.7%, respectively.
In addition, provider ratings were similar before and during the pandemic and between telemedicine and in-person visits.
The researchers noted that the current findings are limited by only having access to aggregate data and suggested that further analysis might determine if any differences are statistically significant.
Read more of Cancer Therapy Advisor’s coverage of SNO 2021 by visiting the conference page.
Petitt Z, Herndon J, Gottfried O, et al. Neuro-oncology outpatient satisfaction is maintained in the era of COVID-19 telemedicine. Presented at SNO 2021; November 18-21, 2021. Abstract INNV-31.